Lion TCR Company

They are a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases in Asia. For the past decade, they have accumulated expertise covering the entire product development process, ranging from basic research, T cell engineering and development, and preclinical/clinical assessment. Led by industry and academic experts from their base in Singapore, they are dedicated to the commercialization and continued development of their immunotherapy products.
Technology: Drug Discovery
Industry: Personalized Medicine
Headquarters: Singapore, Central Region, Singapore
Funding Status: Series A

Visit Website
info@liontcr.com
Register and Claim Ownership